Absence of Gender-Based Differences in Outcome of Patients with Hospital-Acquired Pneumonia

被引:11
作者
Caceres, Fernando [1 ]
Welch, Verna L. [2 ]
Kett, Daniel H. [1 ]
Scerpella, Ernesto G. [2 ]
Peyrani, Paula [3 ]
Ford, Kimbal D. [2 ]
Ramirez, Julio A. [3 ]
机构
[1] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Div Pulm & Crit Care Med, Miami, FL 33156 USA
[2] Pfizer Inc, Specialty Care Med Dev Grp, Collegeville, PA USA
[3] Univ Louisville, Div Infect Dis, Louisville, KY 40292 USA
关键词
VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE UNITS; IMMUNE FUNCTIONS; SEVERE SEPSIS; RISK-FACTORS; MORTALITY; INFECTION; SEX; EPIDEMIOLOGY; PREDICTORS;
D O I
10.1089/jwh.2013.4434
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The objective of this analysis was to evaluate the association between gender and clinical outcomes in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP) since data thus far are controversial. Methods: Data from a convenience sample of ICU patients with HAP, including ventilator-associated and health care-associated pneumonia, were retrospectively collected from four academic institutions (Improving Medicine through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia [IMPACT-HAP] study). Outcomes included 28-day mortality, clinical failure at day 14, hospital and ICU length of stay (LOS), and duration of mechanical ventilation. We compared baseline characteristics and performed multivariate analysis to identify factors independently associated with mortality. Results: Among 416 patients, 271 were men and 145 were women. Women were older (62.416.9 vs. 55.7 +/- 16.5 years, p<0.001) and more critically ill, with Acute Physiology and Chronic Health Evaluation (APACHE) II scores of 21 vs. 19 (p=0.004). Day-28 mortality was 30% for women and 24% for men (p=0.25). Increased 28-day mortality was associated with severity of illness, age, ventilator-associated pneumonia, vascular disease, and hospital LOS prior to pneumonia diagnosis. No significant differences were found in the distribution of bacteria pathogens or in clinical failure rates (36% vs. 31%) between genders. Duration in days of mechanical ventilation, ICU LOS and hospital LOS after the diagnosis of pneumonia were not significantly different between men and women. Analyzing data for women based on presumed pre- or postmenopausal status (age breakpoint of 50 years), showed an increased in ICU LOS (15 vs. 25 days; p=0.0026) and hospital LOS (22 vs. 30 days; p=0.05) for women 50 years. No differences were noted in 28-day mortality (24.3% vs. 13.1%; p=0.18) in women 50 years of age. Conclusions: In ICU patients with pneumonia, female gender was not associated with worse outcomes or increased resource utilization compared to male gender. Further studies are needed to evaluate menopausal status and outcomes in women with pneumonia.
引用
收藏
页码:1069 / 1075
页数:7
相关论文
共 50 条
  • [21] Pharmacotherapy for hospital-acquired pneumonia
    Liapikou, Adamantia
    Rosales-Mayor, Edmundo
    Torres, Antonio
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (06) : 775 - 786
  • [22] Sex Differences in Hospital-Acquired Pneumonia among Patients with Type 2 Diabetes Mellitus Patients: Retrospective Cohort Study using Hospital Discharge Data in Spain (2016-2019)
    Lopez-de-Andres, Ana
    Lopez-Herranz, Marta
    Hernandez-Barrera, Valentin
    de-Miguel-Diez, Javier
    de-Miguel-Yanes, Jose M.
    Carabantes-Alarcon, David
    Albaladejo-Vicente, Romana
    Villanueva-Orbaiz, Rosa
    Jimenez-Garcia, Rodrigo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (23)
  • [23] Hospital-acquired pneumonia pattern in the intensive care units of a governmental hospital: A prospective longitudinal study
    Yakoub, Mina
    Elkhwsky, Fayek
    El Tayar, Ayman
    El Sayed, Iman
    ANNALS OF AFRICAN MEDICINE, 2023, 22 (01) : 94 - 100
  • [24] Original Hospital admissions for community-acquired, ventilator-associated and nonventilator hospital-acquired pneumonia in COPD patients in Spain (2016-2017).
    de Miguel-Diez, Javier
    Albaladejo-Vicente, Romana
    Hernandez-Barrera, Valentin
    Ji, Zichen
    Lopez-Herranz, Marta
    Jimenez-Garcia, Rodrigo
    Lopez-de-Andres, Ana
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 79 : 93 - 100
  • [25] High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia
    Chung, Doo Ryeon
    Song, Jae-Hoon
    Kim, So Hyun
    Thamlikitkul, Visanu
    Huang, Shao-Guang
    Wang, Hui
    So, Thomas Man-kit
    Yasin, Rohani M. D.
    Hsueh, Po-Ren
    Carlos, Celia C.
    Hsu, Li Yang
    Buntaran, Latre
    Lalitha, M. K.
    Kim, Min Ja
    Choi, Jun Yong
    Kim, Sang Il
    Ko, Kwan Soo
    Kang, Cheol-In
    Peck, Kyong Ran
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) : 1409 - 1417
  • [26] Prevention of hospital-acquired pneumonia
    Lyons, Patrick G.
    Kollef, Marin H.
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (05) : 370 - 378
  • [27] Incidence, etiology, and outcome of hospital-acquired pneumonia in patients with acute exacerbation of fibrotic idiopathic interstitial pneumonia
    Yamazaki, Ryo
    Nishiyama, Osamu
    Yosikawa, Kazuya
    Gose, Kyuya
    Oomori, Takashi
    Nishikawa, Yusaku
    Sano, Akiko
    Matsumoto, Hisako
    RESPIRATORY INVESTIGATION, 2024, 62 (03) : 488 - 493
  • [28] Evaluating causative agents, mortality factors, and laboratory data of hospital-acquired pneumonia patients
    Oznur, Emine
    Guzeldag, Seda
    Cakir, Nuri
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (12): : 1846 - 1851
  • [29] Hospital-Acquired Pneumonia: Pathophysiology, Diagnosis, and Treatment
    Kieninger, Alicia N.
    Lipsett, Pamela A.
    SURGICAL CLINICS OF NORTH AMERICA, 2009, 89 (02) : 439 - +
  • [30] Is hospital-acquired pneumonia different in transplant recipients?
    Gudiol, C.
    Sabe, N.
    Carratala, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (10) : 1186 - 1194